Procaps Group マネジメント

マネジメント基準チェック /14

現在、CEO に関する十分な情報がありません。

主要情報

Jose Antonio Vieira

最高経営責任者

n/a

報酬総額

CEO給与比率	n/a
CEO在任期間	less than a year
CEOの所有権	n/a
経営陣の平均在職期間	4.5yrs
取締役会の平均在任期間	1.4yrs

経営陣の近況

Recent updates

These 4 Measures Indicate That Procaps Group (NASDAQ:PROC) Is Using Debt Extensively

Mar 28

CEO（最高経営責任者

Jose Antonio Vieira (58 yo)

less than a year

在職期間

Mr. Jose Antonio Toledo Vieira is Chief Executive Officer of Procaps Group S.A. from January 15, 2024. He has been Member of Advisory Board at Patria Latin American Opportunity Acquisition Corp. since 2022...

リーダーシップ・チーム

名称	ポジション	在職期間	報酬	所有権
Jose Antonio Vieira	Chief Executive Officer	less than a year	データなし	データなし
Patricio Munoz	Global Chief Financial Officer	3.3yrs	データなし	データなし
Camilo Camacho	Chief Operations Officer	no data	データなし	データなし
Melissa Angelini	Investor Relations Director	2.8yrs	データなし	データなし
Marcela Pagano	Vice-President of Corporate & Legal Affairs	11.8yrs	データなし	データなし
Luis Alberto Aragon	Vice-President of International Marketing and R&D	5.8yrs	データなし	データなし
Mauricio Caballero	Vice-President of Human Resources	10.3yrs	データなし	データなし

4.5yrs

平均在職期間

54yo

平均年齢

経験豊富な経営陣: PROCの経営陣は経験豊富であると考えられます ( 4.5年の平均在職年数)。

取締役

名称	ポジション	在職期間	報酬	所有権
Daniel Fink	Board Observer	1.8yrs	データなし	データなし
Jose Gontovnik	Chairman	less than a year	データなし	15.92% $ 12.4m
Kyle Bransfield	Independent Director	3.2yrs	データなし	1.81% $ 1.4m
David Yanovich Wancier	Independent Director	no data	データなし	データなし
Alberto Eguiguren Correa	Independent Director	1.8yrs	データなし	データなし
Luis Castro Vergara	Independent Director	no data	データなし	データなし
Sandra Sanchez Oldenhage	Independent Director	1.1yrs	データなし	データなし
Roberto Albisetti	Independent Director	less than a year	データなし	データなし

1.4yrs

平均在職期間

55yo

平均年齢

経験豊富なボード: PROCの取締役会は経験豊富ではない ( 1.4年の平均在任期間) ため、新しい取締役会が必要であると考えられます。

Procaps Group マネジメント

マネジメント 基準チェック /14

主要情報

経営陣の近況

Procaps Group S.A. Announces Resignation of Ruben Minski as Board of Directors

Procaps Group S.A. Announces Board Changes

Procaps Group S.A. Announces Formation of Strategic Committee to Explore Value Creation Alternatives

Procaps Group S.A. Announces Executive Changes, Effective January 15, 2024

Procaps Group S.A. Announces Executive Changes, Effective January 15, 2024

Procaps Group S.A. Appoints Sandra Sanchez Y Oldenhage as A Director

Recent updates

Procaps Group S.A. Announces Resignation of Ruben Minski as Board of Directors

Hoche Partners Raises Concerns on Shareholder Letter Issued by Procaps Group

Hoche Partners Criticizes Procaps Group's Majority Shareholder for Mismanagement and Rejection of Financial Restructuring Offer

Procaps Group S.A. Announces Board Changes

Procaps Group S.A. announced delayed 20-F filing

Procaps Group S.A. Provides Earnings Guidance for the Year Ended December 31, 2023

These 4 Measures Indicate That Procaps Group (NASDAQ:PROC) Is Using Debt Extensively

Procaps Group S.A. Announces Formation of Strategic Committee to Explore Value Creation Alternatives

Investor sentiment deteriorates as stock falls 23%

Is Procaps Group S.A. (NASDAQ:PROC) Worth US$3.7 Based On Its Intrinsic Value?

New major risk - Revenue and earnings growth

Hoche Partners Sends a Letter to Procaps Group

Hoche Partners Sends a Letter to Procaps Group

Investor sentiment improves as stock rises 16%

Third quarter 2023 earnings released: EPS: US$0.08 (vs US$0.22 in 3Q 2022)

Investor sentiment deteriorates as stock falls 19%

Procaps Group S.A. Announces Executive Changes, Effective January 15, 2024

Procaps Group S.A. Announces Executive Changes, Effective January 15, 2024

Investor sentiment deteriorates as stock falls 17%

Procaps Group S.A. to Report Q3, 2023 Results on Nov 14, 2023

New minor risk - Share price stability

Investor sentiment improves as stock rises 23%

Procaps Group S.A. Appoints Sandra Sanchez Y Oldenhage as A Director

Investor sentiment deteriorates as stock falls 19%

Second quarter 2023 earnings released: EPS: US$0.27 (vs US$0.068 loss in 2Q 2022)

Procaps Group S.A. to Report Q2, 2023 Results on Sep 05, 2023

Procaps Group S.A., Annual General Meeting, Jun 30, 2023

Procaps Group S.A. to Report Q1, 2023 Results on Jun 05, 2023

Consensus EPS estimates fall by 28%

Full year 2022 earnings released: EPS: US$0.42 (vs US$1.03 loss in FY 2021)

Investor sentiment improves as stock rises 18%

Investor sentiment improves as stock rises 15%

Now 21% undervalued after recent price drop

Investor sentiment improves as stock rises 15%

Less than half of directors are independent

Procaps Group S.A. Announces Board Changes

Procaps Group S.A. (NasdaqGM:PROC) announces an Equity Buyback for 2,000,000 shares, for $5 million.

Now 22% undervalued after recent price drop

Calculating The Intrinsic Value Of Procaps Group S.A. (NASDAQ:PROC)

Investor sentiment deteriorates as stock falls 16%

Procaps Group Announces Key Changes to the Board of Directors

Price target increased to US$13.00

Investor sentiment deteriorated over the past week

Third quarter 2022 earnings released

Procaps Group S.A. to Report Q3, 2022 Results on Nov 14, 2022

Now 22% undervalued after recent price drop

Now 23% undervalued after recent price drop

Second quarter 2022 earnings released: US$0.07 loss per share (vs US$0.01 loss in 2Q 2021)

Procaps Group reports Q2 results

Now 20% undervalued after recent price drop

First quarter 2022 earnings released: EPS: US$0.16 (vs US$0.18 loss in 1Q 2021)

Procaps Group S.A., Annual General Meeting, Jun 28, 2022

Procaps Group S.A. (NasdaqGM:PROC) entered into an agreenment to acquire Grupo Farmacéutico Somar, Sociedad Anónima Promotora de Inversión de Capital Variable from Advent International Corporation.

Procaps Group S.A. (NasdaqGM:PROC) entered into an agreenment to acquire Grupo Farmacéutico Somar, Sociedad Anónima Promotora de Inversión de Capital Variable from Advent International Corporation.

Forecast to breakeven in 2022

Now 20% undervalued after recent price drop

Forecast to breakeven in 2022

Procaps Group Announces Appointment of Melissa Angelini as Investor Relations Director

Procaps Group, S.A. (NasdaqGM:PROC) acquired 86,000 sq. ft. Pharmaceutical Production Facility Located in West Palm Beach, Florida from Strides Pharma Inc.

Calculating The Fair Value Of Procaps Group, S.A. (NASDAQ:PROC)

CEO（最高経営責任者

在職期間

リーダーシップ・チーム

平均在職期間

平均年齢

取締役

平均在職期間

平均年齢

マネジメント基準チェック /14